Sponsor Pipeline

Hellenic Society of Hematology Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1/2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06636552 An Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective… Primary Plasma Cell Leukemia Recruiting
NCT07019545 A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB… Primary Immune Thrombocytopenia (ITP) Not Yet Recruiting
Phase 1/2
NCT05573802 A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in… Multiple Myeloma Recruiting
NCT05581875 A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in… Multiple Myeloma Not Yet Recruiting
NCT04808037 Blmf, Lenalidomide and Dexamethasone in Transplant-ineligible Patients With Newly… Multiple Myeloma Active, Not Recruiting
Disease Areas
Get alerts when Hellenic Society of Hematology's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free